Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan
· Delayed Price · Currency is JPY 2,559.00
-71.00 (-2.70%)
Apr 3, 2025, 2:45 PM JST
Towa Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 2, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Market Capitalization | 129,467 | 142,933 | 93,275 | 135,736 | 120,231 | 111,557 | Upgrade
|
| Market Cap Growth | 42.67% | 53.24% | -31.28% | 12.90% | 7.78% | -22.18% | Upgrade
|
| Enterprise Value | 323,694 | 308,406 | 222,967 | 195,152 | 187,298 | 142,573 | Upgrade
|
| Last Close Price | 2630.00 | 2834.87 | 1812.42 | 2550.37 | 2222.80 | 2024.46 | Upgrade
|
| PE Ratio | 6.71 | 8.84 | 42.38 | 8.53 | 8.61 | 7.69 | Upgrade
|
| Forward PE | 8.22 | 11.99 | 11.96 | 8.06 | 10.11 | 9.65 | Upgrade
|
| PS Ratio | 0.51 | 0.63 | 0.45 | 0.82 | 0.78 | 1.01 | Upgrade
|
| PB Ratio | 0.77 | 0.92 | 0.68 | 1.03 | 1.03 | 1.07 | Upgrade
|
| P/TBV Ratio | 1.36 | 1.36 | 1.11 | 1.74 | 1.18 | 1.28 | Upgrade
|
| P/FCF Ratio | - | - | 12.35 | 41.88 | 7.63 | Upgrade
| |
| P/OCF Ratio | 10.64 | 17.41 | 36.67 | 6.13 | 10.01 | 5.82 | Upgrade
|
| EV/Sales Ratio | 1.28 | 1.35 | 1.07 | 1.18 | 1.21 | 1.29 | Upgrade
|
| EV/EBITDA Ratio | 7.80 | 8.68 | 8.95 | 6.62 | 6.17 | 5.83 | Upgrade
|
| EV/EBIT Ratio | 14.68 | 17.48 | 40.43 | 10.53 | 9.40 | 8.82 | Upgrade
|
| EV/FCF Ratio | -15.02 | - | - | 17.76 | 65.24 | 9.76 | Upgrade
|
| Debt / Equity Ratio | 1.32 | 1.32 | 1.26 | 1.09 | 0.73 | 0.79 | Upgrade
|
| Debt / EBITDA Ratio | 5.39 | 5.80 | 6.94 | 4.89 | 2.79 | 3.37 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 13.12 | 29.53 | 5.64 | Upgrade
|
| Asset Turnover | 0.58 | 0.57 | 0.60 | 0.57 | 0.65 | 0.53 | Upgrade
|
| Inventory Turnover | 1.55 | 1.51 | 1.64 | 1.43 | 1.61 | 1.35 | Upgrade
|
| Quick Ratio | 1.38 | 1.26 | 1.00 | 0.73 | 1.33 | 0.87 | Upgrade
|
| Current Ratio | 3.02 | 2.72 | 2.33 | 1.45 | 2.67 | 1.73 | Upgrade
|
| Return on Equity (ROE) | 12.13% | 11.05% | 1.64% | 12.79% | 12.62% | 14.77% | Upgrade
|
| Return on Assets (ROA) | 3.16% | 2.75% | 0.98% | 4.03% | 5.26% | 4.85% | Upgrade
|
| Return on Capital (ROIC) | 3.74% | 3.28% | 1.18% | 4.85% | 6.41% | 5.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.80% | 5.00% | 1.90% | 8.60% | 10.30% | 10.20% | Upgrade
|
| Earnings Yield | 14.89% | 11.31% | 2.36% | 11.72% | 11.61% | 13.00% | Upgrade
|
| FCF Yield | -16.65% | -20.74% | -28.07% | 8.10% | 2.39% | 13.10% | Upgrade
|
| Dividend Yield | 2.96% | 2.12% | 3.31% | 2.23% | 1.98% | 2.17% | Upgrade
|
| Payout Ratio | 15.34% | 18.25% | 140.84% | 15.15% | 15.52% | 14.25% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | 0.00% | 2.19% | 1.86% | 3.57% | -0.01% | Upgrade
|
| Total Shareholder Return | 2.96% | 2.12% | 5.50% | 4.09% | 5.54% | 2.16% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.